Partner Chris Grigorian was quoted in a Law360 article, “The 4 Hottest Practice Areas for 2018,” about how the autonomous vehicle industry is continuing to pose new public policy questions and legal issues for corporations in the automotive space.
Legislation that would likely accelerate getting more autonomous vehicles on the road, providing the federal government preemption over states with regard to the regulation of their design, construction and performance, has passed the House and is working its way through the Senate.
If the bills become law, Grigorian said he anticipates a surge in legal work in 2018 as federal regulators engage in congressionally mandated rulemaking, such as amending the federal motor vehicle safety standards to remove barriers to the development of autonomous vehicles and expanding exemptions to facilitate the development and field testing of self-driving cars.
“We anticipate working closely with our clients throughout the rulemaking process and, subsequently, guiding them through the compliance challenges that will inevitably arise in this emerging area,” he said.
Legislation that would likely accelerate getting more autonomous vehicles on the road, providing the federal government preemption over states with regard to the regulation of their design, construction and performance, has passed the House and is working its way through the Senate.
If the bills become law, Grigorian said he anticipates a surge in legal work in 2018 as federal regulators engage in congressionally mandated rulemaking, such as amending the federal motor vehicle safety standards to remove barriers to the development of autonomous vehicles and expanding exemptions to facilitate the development and field testing of self-driving cars.
“We anticipate working closely with our clients throughout the rulemaking process and, subsequently, guiding them through the compliance challenges that will inevitably arise in this emerging area,” he said.
People
Related News
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."
July 18, 2025
In the News
Aaron Maguregui Highlights Potential Compliance Concerns in Pre-Tax Wellness Claims
Foley & Lardner LLP partner Aaron Maguregui commented in The New York Times article, "Hot Dogs for Insomnia? A Kennedy Aide's Start-Up Can Get You a Tax Break," sharing insight on the growing use of medical necessity letters to support tax-advantaged purchases of wellness products.